Peptide affinity reagents for AAV capsid recognition and purification

Gene Therapy

Volumn 18, Issue 10, 2011, Pages 1020-1024

  Pulicherla, N ^a   Asokan, A ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

AAV vectors; affinity column chromatography; phage display

Indexed keywords

GLYCYLTYROSYLVALYLSERYLARGINYLHIDTIDYLPROLINE; HEPTAPEPTIDE; MONOCLONAL ANTIBODY; PARVOVIRUS VECTOR; UNCLASSIFIED DRUG;

ANION EXCHANGE CHROMATOGRAPHY; ARTICLE; CELL LYSATE; COLUMN CHROMATOGRAPHY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PURIFICATION; SEROTYPE; VIRUS CAPSID;

AMINO ACID MOTIFS; CAPSID; CELL LINE; CHROMATOGRAPHY, AFFINITY; CHROMATOGRAPHY, ION EXCHANGE; DEPENDOVIRUS; DNA PRIMERS; GENETIC VECTORS; HUMANS; PEPTIDES;

MIRIDAE;

EID: 80054062407     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2011.46     Document Type: Article

References (20)

1. Vandenberghe LH, Breous E, Nam HJ, Gao G, Xiao R, Sandhu A et al. Naturally occurring singleton residues in AAV capsid impact vector performance and illustrate structural constraints. Gene Therapy 2009; 16: 1416-1428.
2. Mitchell AM, Nicolson SC, Warischalk JK, Samulski RJ. AAV's anatomy: roadmap for optimizing vectors for translational success. Curr Gene Ther 2010; 10: 319-340.
3. Aucoin MG, Perrier M, Kamen AA. Critical assessment of current adeno-associated viral vector production and quantification methods. Biotechnol Adv 2008; 26: 73-88. (Pubitemid 350148247)
4. Wright JF. Transient transfection methods for clinical adeno-associated viral vector production. Hum Gene Ther 2009; 20: 698-706.
5. Clement N, Knop DR, Byrne BJ. Large-scale adeno-associated viral vector production using a herpesvirus-based system enables manufacturing for clinical studies. Hum Gene Ther 2009; 20: 796-806.
6. Zhang H, Xie J, Xie Q, Wilson JM, Gao G. Adenovirus-adeno-associated virus hybrid for large-scale recombinant adeno-associated virus production. Hum Gene Ther 2009; 20: 922-929.
7. Virag T, Cecchini S, Kotin RM. Producing recombinant adeno-associated virus in foster cells: overcoming production limitations using a baculovirus-insect cell expression strategy. Hum Gene Ther 2009; 20: 807-817.
8. Zolotukhin S, Byrne BJ, Mason E, Zolotukhin I, Potter M, Chesnut K et al. Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Therapy 1999; 6: 973-985. (Pubitemid 29295202)
9. Zolotukhin S, Potter M, Zolotukhin I, Sakai Y, Loiler S, Fraites TJ et al. Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors. Methods 2002; 28: 158-167. (Pubitemid 35341079)
10. Smith RH, Yang L, Kotin RM. Chromatography-based purification of adeno-associated virus. Methods Mol Biol 2008; 434: 37-54.
11. Lock M, Alvira M, Vandenberghe LH, Samanta A, Toelen J, Debyser Z et al. Rapid, simple, and versatile manufacturing of recombinant adeno-associated viral vectors at scale. Hum Gene Ther 2010; 21: 1259-1271.
12. Arnold GS, Sasser AK, Stachler MD, Bartlett JS. Metabolic biotinylation provides a unique platform for the purification and targeting of multiple AAV vector serotypes. Mol Ther 2006; 14: 97-106. (Pubitemid 43922139)
13. Koerber JT, Jang JH, Yu JH, Kane RS, Schaffer DV. Engineering adeno-associated virus for one-step purification via immobilized metal affinity chromatography. Hum Gene Ther 2007; 18: 367-378. (Pubitemid 46709348)
14. Smith RH, Levy JR, Kotin RM. A simplified baculovirus-AAV expression vector system coupled with one-step affinity purification yields high-titer rAAV stocks from insect cells. Mol Ther 2009; 17: 1888-1896.
15. Sergeeva A, Kolonin MG, Molldrem JJ, Pasqualini R, Arap W. Display technologies: application for the discovery of drug and gene delivery agents. Adv Drug Deliv Rev 2006; 58: 1622-1654. (Pubitemid 44830148)
16. Petrenko V. Evolution of phage display: from bioactive peptides to bioselective nanomaterials. Expert Opin Drug Deliv 2008; 5: 825-836.
17. Vandenberghe LH, Xiao R, Lock M, Lin J, Korn M, Wilson JM. Efficient serotypedependent release of functional vector into the culture medium during adeno-associated virus manufacturing. Hum Gene Ther 2010; 21: 1251-1257.
18. Grieger JC, Choi VW, Samulski RJ. Production and characterization of adeno-associated viral vectors. Nat Protoc 2006; 1: 1412-1428.
19. Wobus CE, Hugle-Dorr B, Girod A, Petersen G, Hallek M, Kleinschmidt JA. Monoclonal antibodies against the adeno-associated virus type 2 (AAV2) capsid: epitope mapping and identification of capsid domains involved in AAV-2-cell interaction and neutralization of AAV-2 infection. J Virol 2000; 74: 9281-9293.
20. Rabinowitz JE, Rolling F, Li C, Conrath H, Xiao W, Xiao X et al. Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity. J Virol 2002; 76: 791-801. (Pubitemid 34033377)